Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 12, 2025
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 05, 2021
Combinatorial mRNA binding by AUF1 and Argonaute 2 controls decay of selected target mRNAs.
Journal: Nucleic acids research
Published: January 11, 2013
Showing 1-3 of 3
Last Updated: 09/26/2026